Sort
30,917 grants matching “tumor microenvironment”
TME CoBRE Administration Core
$430,020Paul R Lockman · West Virginia University · P20 · FY2018 · GM
IGFBP1 mediates a liver-bone-muscle axis in colorectal cancer cachexia
$429,999Andrea Bonetto · University Of Colorado Denver · R01 · FY2023 · AR
Regulation of CD8+T cells by Zbtb42
$429,966Venuprasad K Poojary · Ut Southwestern Medical Center · R01 · FY2025 · CA
Endothelial Cell Activation Regulates AML Growth and Relapse
$429,874Gerard James Madlambayan · Oakland University · R15 · FY2014 · CA
Reprogramming the pancreatic tumor microenvironment with immunotherapy
$429,841Lei Zheng · Johns Hopkins University · R01 · FY2017 · CA
Project 2: Combined CAR-T cell therapy
$429,640Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2024 · CA
How does EGFR facilitate the constitutive activation of STAT3 in tumors?
$429,633George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2018 · CA
How does EGFR facilitate the constitutive activation of STAT3 in tumors?
$429,633George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2020 · CA
Spatial Analysis of Molecules in Tissue using MALDI-MS
$429,623Richard M Caprioli · Vanderbilt University · R01 · FY2015 · GM
Spatial Analysis of Molecules in Tissue using MALDI-MS
$429,623Richard M Caprioli · Vanderbilt University · R01 · FY2014 · GM
Deconstruct tumor microenvironment in medulloblastoma
$429,572Hui Zong · University Of Virginia · R01 · FY2017 · NS
Project 2: Effect of HTLV-1 Viral Oncogenes on the Bone Microenvironment during tumor growth and progression in ATL
$429,511Deborah V Novack · Ohio State University · P01 · FY2023 · CA
Drug Mechanism of Action-based targeting of tumor subpopulations
$429,473Andrea Califano · Columbia University Health Sciences · U54 · FY2024 · CA
Mechanisms of cellular crosstalk in tumor-promoting niche formation
$429,466Naoki Oshimori · Oregon Health & Science University · R01 · FY2021 · CA
Extracellular vesicle enclosed circular RNA and interferon responses in tumor host interactions.
$429,399Dolores Di Vizio · Cedars-Sinai Medical Center · R21 · FY2025 · CA
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium
$429,377Robert M Straubinger · State University Of New York At Buffalo · R01 · FY2017 · CA
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium
$429,377Robert M Straubinger · State University Of New York At Buffalo · R01 · FY2016 · CA
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium
$429,377Robert M Straubinger · State University Of New York At Buffalo · R01 · FY2018 · CA
Cold-responsive gene and drug delivery-potentiated cryoimmunotherapy
$429,350Xiaoming He · Univ Of Maryland, College Park · R01 · FY2024 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$429,318James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Development of Salmonella vaccines for cancer and viruses
$429,260Olivia Steele-Mortimer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Evaluation of the Efficacy of Trametinib + Navitoclax in recurrent ovarian carcinoma
$429,166Ursula Anne Matulonis · Dana-Farber Cancer Inst · P50 · FY2020 · CA
Hypoxia-derived molecular MSI signatures to predict breast cancer outcome
$429,142Kristine Glunde · Johns Hopkins University · R01 · FY2019 · CA
Role of Erbb3 kinase activity in colorectal tumorigenesis.
$429,115Zhenghe Wang · Case Western Reserve University · R01 · FY2024 · CA
Elucidating the Role of Mechanics and Lymphatic Pumping on Lymphovascular Space Invasion Using a Lympho-vascularized Breast-Skin Platform
$429,114Marissa N Rylander · University Of Texas At Austin · · FY2024 · ENG